Delivery Order SPE2DE24D0013-SPE2D626F746V
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- Cepheid Inc., a leading manufacturer of molecular diagnostic systems headquartered in Sunnyvale, California, has been awarded a delivery order valued at $8,976 under contract 4570051105 for XPCOV2/FLU/RSV-10 diagnostic products. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain on November 18, 2025, with no set-aside designation. The contract delivers diagnostic testing supplies and...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,040 on December 1, 2025, by the Defense Logistics Agency Medical Supply Chain. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 8, 2025. Performance will take place at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $4,080 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for the detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc. has been awarded a delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with an ultimate completion date of December 2, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F746VDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, was awarded a delivery order valued at $8,976 on December 3, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as XPCOV2/FLU/RSV-10, is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and carries no set-aside designation. The contract supports the procurement of diagnostic testing supplies, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV) on the GeneXpert diagnostic platform. This delivery order represents a routine procurement action under Cepheid's established federal contracting relationship with the Defense Logistics Agency, which has issued numerous delivery orders for diagnostic testing supplies and reagents. As a primary federal supplier of molecular diagnostic solutions, Cepheid serves multiple federal healthcare agencies including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service, leveraging its GeneXpert platform for rapid infectious disease detection. The relatively modest contract value reflects a single ordering period draw against the agency's broader diagnostic supply procurement requirements within the Military Health System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 12/2/25 |